A passing line in my recent post on cancer drug pricing made
reference to the financial burden faced by American cancer patients: an
American Cancer Society publication posted online today indicates that the
burden among “non-elderly” cancer survivors (those under 65 years old) is
sufficient to make this group more likely to delay, skip or even forgo
medication than those without a history of cancer.
Zeng and colleagues examined National Health Interview Survey
data from 9,000 individuals with, and 93,000 individuals without, a history of
cancer. They found 31.6% of respondents recently diagnosed with cancer and
27.9% of those with a past cancer
diagnosis had made some change in prescription drug use for financial reasons, compared with 21.4% of
respondents without a cancer history.
Cancer survivors in health plans with lower premiums but with a higher
threshold before costs are met (“high deductible” plans) were more likely to
request lower cost medications than those without a cancer history (32% vs.
22.5%, respectively).
A shift away from hospital or community-administered infused
cancer drugs towards self-administered oral medications, along with changes in
health plan structure have increased the out-of-pocket burden, with those under
65 (and not enrolled in Medicare) being hardest hit.
The authors did look at the impact of cost-imposed changes
in medication on quality of life but conclude by proposing that prescribers
should consider the consequences of financial burden and shape their treatment
decisions accordingly.
People with Cancer
History More Likely to Change Prescriptions to Save Money. American Cancer
Society press release online February 20th 2017. http://tinyurl.com/hkk7xcb
Do cancer survivors change their prescription drug use for
financial reasons? Findings from a nationally representative sample in the
United States.Zeng Z et al. Cancer.
doi:10.1002/cncr.30560. Published online February 20th 2017. http://tinyurl.com/jjtabyu (Subscription
required for full text).
For a perspective on what changes in the Affordable Care Act might mean for American cancer patients, read Julia Belluz's Voxmedia piece "Cancer can bankrupt its victims. Obamacare was designed to stop that".Online 23rd February 2017.
No comments:
Post a Comment